Rapid advances in AI have significant implications for nuclear and biosecurity, including benefits and risks for nuclear weapons systems and the growing bioeconomy. Managing these new capabilities to ensure they aren’t misused to undermine strategic stability or cause a global biological catastrophe will require coordinated leadership, new guardrails, and innovative policy approaches.
NTI Co-Chair and CEO Ernest J. Moniz hosted Eric Schmidt, former CEO and chairman of Google, for a conversation about how today’s emerging technologies will fundamentally alter global security—and society at large.
Preventing global catastrophic biological risks (GCBRS)
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.
For as long as we have nuclear weapons, the United States must ensure they are safe, secure, and reliable.
NTI | bio convened more than 25 high-level biosecurity professionals, AI experts, and policymakers for the inaugural meeting of the International AI-Bio Forum.
To reduce biosecurity risks that arise at the intersection of AI and the life sciences, NTI | bio convened experts in synthetic biology, machine learning, bioinformatics, and international security policy to outline steps toward establishing an international AI-Bio Forum.
NTI Co-Chair and CEO Ernest J. Moniz hosted Eric Schmidt, former CEO and chairman of Google, for a conversation about how today’s emerging technologies will fundamentally alter global security—and society at large.
NTI hosted a wide-ranging discussion on the implications of artificial intelligence technologies for nuclear and biosecurity at its Board of Directors dinner in Washington, D.C.
NTI | bio’s Dr. Aparupa Sengupta joined a groundbreaking discussion on the nexus of cyber- and bio-security.
See All Analysis on Artificial Intelligence and Machine Learning
